Compounds of the formula I: ##STR00001## or pharmaceutically acceptable salts thereof, wherein Ar, X, m, R.sup.1, R.sup.2 are as defined herein. Also provided are methods for preparing, compositions comprising, and methods for using compounds of formula I for treatment of 5-HT6-mediated diseases.